Author

Katharina L. Kopp

Institution: Novo Nordisk (Denmark)

Observed institution: Novo Nordisk (Denmark)

OpenAlex ID: A5144039752

Impurities and Potential Immunogenicity Associated With Follow-on and Compounded Glucagon-like Peptide-1 Receptor Agonists

2026 · Katharina L. Kopp, Kasper Lamberth, et al. · Pharmaceutical Research · 1

Development of Inno8, an orally administered factor VIIIa-mimetic antibody fragment for treatment of hemophilia A

2026 · Jacob Lund, Jais Rose Bjelke, et al. · Blood

Works count: 3

Citation count: 6

H-index: 1

I10-index: